Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
Journal of Comparative Effectiveness Research|September 13, 2019
Guidance for a causal comparative effectiveness analysis emulating a target trial based on big real world evidence: when to start statin treatmentFelicitas Kuehne, Beate Jahn, Annette Conrads-Frank, et al.
JAMA Network Open|November 28, 2023
Projected Life Expectancy Gains From Improvements in HIV Care in Black and White Men Who Have Sex With MenKatherine M Rich, Ankur Pandya, John J Chiosi, et al.
Stroke|May 13, 2021
Access to Mechanical Thrombectomy for Ischemic Stroke in the United StatesHooman Kamel, Neal S Parikh, Abhinaba Chatterjee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 4, 2025
Clinical consequences of delaying implementation of long-acting antiretroviral therapy for people with HIV and persistent viremia in the USPamela P Pei, Michelle Jones, Ruitian Hu, et al.
JAMA Cardiology|May 14, 2020
Cost-effectiveness of Contemporary Statin Use Guidelines With or Without Coronary Artery Calcium Assessment in African American IndividualsAferdita Spahillari, Jinyi Zhu, Bart S Ferket, et al.
AIDS (London, England)|June 21, 2021
Attributing health benefits to preventing HIV infections versus improving health outcomes among people living with HIV: an analysis in six US citiesEmanuel Krebs, Eva Enns, Xiao Zang, et al.
Global Heart|April 23, 2016
Comparison of Nonblood-Based and Blood-Based Total CV Risk Scores in Global PopulationsThomas A Gaziano, Shafika Abrahams-Gessel, Sartaj Alam, et al.
The Journal of Infectious Diseases|September 3, 2020
Ending the HIV Epidemic Among Persons Who Inject Drugs: A Cost-Effectiveness Analysis in Six US CitiesEmanuel Krebs, Xiao Zang, Benjamin Enns, et al.
The Lancet. HIV|March 9, 2020
Ending the HIV epidemic in the USA: an economic modelling study in six citiesBohdan Nosyk, Xiao Zang, Emanuel Krebs, et al.
Medrxiv : the Preprint Server for Health Sciences|January 2, 2026
Costs associated with increasing numbers of Medicare beneficiaries with HIV aged 65 years and older from 2026 to 2035Emily P Hyle, Luke Ang, Grace Luu, et al.
Pageof 14